T.C. Kok

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

J.G.M. Klijn, A.M. Hoff, A.S.T. Planting et al. · British Journal of Cancer · 1990 · 87 citations · Full text

Medicine, Endocrinology, Oncology +16

Activity of cisplatin in adenocarcinoma of the pancreas

J. Wils, T.C. Kok, D. J. Th. Wagener et al. · European Journal of Cancer · 1993 · 78 citations

Medicine, Oncology, Pharmacology +9

Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas

T. A. W. Splinter, H. Obertop, T.C. Kok et al. · Journal of Cancer Research and Clinical Oncology · 1989 · 49 citations · Full text

Medicine, Oncology, Surgery +12

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer

M.E.L. van der Burg, Wendy Onstenk, Ingrid Boere et al. · European Journal of Cancer · 2014 · 39 citations

Medicine, Gynecology, Oncology +12